Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Head and Neck Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04003051
What this trial is testing

Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies

Who this might be right for
Throat Carcinoma
M.D. Anderson Cancer Center 300
Early research (Phase 1)Study completedNCT00623831
What this trial is testing

Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

Who this might be right for
MelanomaSarcomaGastrointestinal Stromal Tumor (GIST)+6 more
Ludwig Institute for Cancer Research 17
Testing effectiveness (Phase 2)Ended earlyNCT02924675
What this trial is testing

Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer.

Who this might be right for
Earache
University Hospital, Lille 42
Not applicableStudy completedNCT05936502
What this trial is testing

Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaExtranodal ExtensionHuman Papilloma Virus Related Carcinoma
Head and Neck Cancer International Group 3,500
Large-scale testing (Phase 3)Study completedNCT03358472
What this trial is testing

Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)

Who this might be right for
Head and Neck Cancer
Incyte Corporation 89
Not applicableUnknownNCT05644457
What this trial is testing

Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck

Who this might be right for
Head and Neck Cancer
Royal Marsden NHS Foundation Trust 50
Testing effectiveness (Phase 2)Study completedNCT04555837
What this trial is testing

Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaMalignant Solid Neoplasm
M.D. Anderson Cancer Center 24
Early research (Phase 1)Study completedNCT00437372
What this trial is testing

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Who this might be right for
CancerHead and Neck CancerPelvic Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 39
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Not applicableActive Not RecruitingNCT03114501
What this trial is testing

Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers

Who this might be right for
Malignant Neoplasms of Lip Oral Cavity and PharynxHead and Neck Cancer
M.D. Anderson Cancer Center 236
Not applicableStudy completedNCT03049280
What this trial is testing

Prospective, Multicenter da Vinci® SP™ Surgical System TORS Study

Who this might be right for
Oropharyngeal Cancer
Intuitive Surgical 33
Not applicableStudy completedNCT02724488
What this trial is testing

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

Who this might be right for
Head and Neck CancerMelanoma
University Health Network, Toronto 14
Testing effectiveness (Phase 2)UnknownNCT01697891
What this trial is testing

A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers

Who this might be right for
Head and Neck CancerDysphagia
McMaster University 35
Early research (Phase 1)Study completedNCT00622674
What this trial is testing

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 37
Not applicableStudy completedNCT00316823
What this trial is testing

Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules

Who this might be right for
Head and Neck Cancer
University of California, San Francisco 400
Not applicableStudy completedNCT04382079
What this trial is testing

Honey Products for Cancer Patients With Oral Mucositis: a Randomized Controlled Trial

Who this might be right for
Oral Mucositis
Taipei Medical University 75
Testing effectiveness (Phase 2)Ended earlyNCT02542215
What this trial is testing

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

Who this might be right for
Oral Mucositis
Sucampo Pharma Americas, LLC 47
Testing effectiveness (Phase 2)Study completedNCT00703976
What this trial is testing

Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer

Who this might be right for
Cancer
University of Pittsburgh 80
Early research (Phase 1)Study completedNCT04902027
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers

Who this might be right for
Recurrent Head and Neck CancerMetastatic Head and Neck Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 45
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Next Page